These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 23089540

  • 1. Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy.
    Li T, Huang S, Dong M, Gui Y, Wu D.
    Urol Oncol; 2013 Nov; 31(8):1539-45. PubMed ID: 23089540
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression profile of CD44s, CD44v6, and CD44v10 in localized prostate cancer: effect on prognostic outcomes following radical prostatectomy.
    Tei H, Miyake H, Harada K, Fujisawa M.
    Urol Oncol; 2014 Jul; 32(5):694-700. PubMed ID: 24468288
    [Abstract] [Full Text] [Related]

  • 7. Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia.
    Nägler DK, Krüger S, Kellner A, Ziomek E, Menard R, Buhtz P, Krams M, Roessner A, Kellner U.
    Prostate; 2004 Jul 01; 60(2):109-19. PubMed ID: 15162377
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectomy.
    Giesing M, Suchy B, Driesel G, Molitor D.
    BJU Int; 2010 Apr 01; 105(7):1000-10. PubMed ID: 19818074
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increased nuclear factor erythroid 2-related factor 2 expression predicts worse prognosis of prostate cancer patients treated with radical prostatectomy.
    Raatikainen S, Aaltomaa S, Kärjä V, Soini Y.
    Hum Pathol; 2014 Nov 01; 45(11):2211-7. PubMed ID: 25175169
    [Abstract] [Full Text] [Related]

  • 12. Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy.
    Wang Q, Diao X, Sun J, Chen Z.
    Urol Oncol; 2013 Apr 01; 31(3):312-7. PubMed ID: 21367627
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
    Debiais-Delpech C, Godet J, Pedretti N, Bernard FX, Irani J, Cathelineau X, Cussenot O, Fromont G.
    Urol Oncol; 2014 May 01; 32(4):426-32. PubMed ID: 24332637
    [Abstract] [Full Text] [Related]

  • 16. L-dopa decarboxylase (DDC) gene expression is related to outcome in patients with prostate cancer.
    Koutalellis G, Stravodimos K, Avgeris M, Mavridis K, Scorilas A, Lazaris A, Constantinides C.
    BJU Int; 2012 Sep 01; 110(6 Pt B):E267-73. PubMed ID: 22571720
    [Abstract] [Full Text] [Related]

  • 17. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
    Noordzij MA, van Steenbrugge GJ, Verkaik NS, Schröder FH, van der Kwast TH.
    Clin Cancer Res; 1997 May 01; 3(5):805-15. PubMed ID: 9815753
    [Abstract] [Full Text] [Related]

  • 18. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.
    Freedland SJ, Seligson DB, Liu AY, Pantuck AJ, Paik SH, Horvath S, Wieder JA, Zisman A, Nguyen D, Tso CL, Palotie AV, Belldegrun AS.
    Prostate; 2003 Apr 01; 55(1):71-80. PubMed ID: 12640663
    [Abstract] [Full Text] [Related]

  • 19. Significance of micrometastases in pelvic lymph nodes detected by real-time reverse transcriptase polymerase chain reaction in patients with clinically localized prostate cancer undergoing radical prostatectomy after neoadjuvant hormonal therapy.
    Miyake H, Kurahashi T, Hara I, Takenaka A, Fujisawa M.
    BJU Int; 2007 Feb 01; 99(2):315-20. PubMed ID: 17155986
    [Abstract] [Full Text] [Related]

  • 20. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
    Zhang Q, Helfand BT, Jang TL, Zhu LJ, Chen L, Yang XJ, Kozlowski J, Smith N, Kundu SD, Yang G, Raji AA, Javonovic B, Pins M, Lindholm P, Guo Y, Catalona WJ, Lee C.
    Clin Cancer Res; 2009 May 15; 15(10):3557-67. PubMed ID: 19447876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.